Furthermore, disrupting the bivalent epigenetic state through EZH2 inhibition was shown to both reduce self-renewal of CRC patient-derived CSCs and upregulate expression of differentiation genes, resulting in increased sensitivity to 5-FU in vivo [171]. Here, EZH2 is linked to colorectal carcinoma.